Agent Capital
Edit

Agent Capital

http://www.agentcapital.com
Last activity: 03.02.2025
Active
Invests in categories: PlatformBioTechDevelopmentHealthTechInvestmentActiveLearnDrugTechnologyCar
Agent Capital is a healthcare investment firm focused on novel technologies and therapeutics that address unmet patient need. Our investment areas of focus are new products and technologies for oncology, immunology, neurology and rare disease indications. We make direct equity investments across all stages of development and types of financing rounds.
Portfolio
19
Mentions
7
Location: United States, Massachusetts, Waltham
Employees: 1-10
Founded date: 2016
Investment Type: Venture Capital

Portfolio 19

DateNameWebsiteTotal RaisedLocation
27.04.2023Foresight ...foresight-dx.com$132.75MUnited Sta...
22.06.2022Carbon Bio...carbonbio.com$38MUnited Sta...
-Orbus Ther...orbustherapeutics.com$103.5MCanada
-Interiusinteriusbio.com$76MUnited Sta...
-Freenomefreenome.com$1.05BUnited Sta...
-Carisma Th...carismatx.com$159MUnited Sta...
-Precision ...precisionbiosciences.com$135.6MUnited Sta...
-Pliant The...pliantrx.com$207MUnited Sta...
-Orchard Th...orchard-tx.com$706MUnited Kin...
-Aptinyx In...aptinyx.com$135MUnited Sta...
Show more

Mentions in press and media 7

DateTitleDescription
03.02.2025Hone Health: $33 Million (Series A) Raised And ivee AcquisitionHone Health, a leading telehealth clinic specializing in preventative and proactive longevity care, announced that it crossed 300,000 patients tested, 55,000 patients treated, and completed a $33 million Series A funding round with particip...
31.01.2025Hone Health Raises $33M to Make Aging OptionalIn an era where chronic diseases increasingly impact quality of life, the healthcare system continues to focus on reactive treatment rather than prevention. Many individuals in their mid-30s and beyond experience symptoms like weight gain, ...
29.01.2025SafelyYou secures $43M for AI-assisted senior living and more funding newsPhoto: Halfpoint Images/Getty Images SafelyYou, maker of AI-enabled technology for fall detection and prevention, closed a $43 million Series C funding round led by Touring Capital, bringing its total raise to more than $100 million. Samsun...
23.11.2024TRexBio: $84 Million (Series B) Closed To Decode Human Tissue Immune BiologyTRex Bio – a biotechnology company decoding human tissue immune biology to create revolutionary therapeutics – announced the closing of an oversubscribed $84 million Series B funding round. This funding was led by Delos Capital, with additi...
25.04.2024Cerevance Secures $47M to Drive Innovation in CNS TherapeuticsCerevance, a Boston-based company specializing in precision treatments for central nervous system (CNS) disorders, recently closed a $47 million Series B-1 Extension financing round. The funding, led by Agent Capital, Bioluminescence Ventur...
25.04.2024Cerevance Raises $47M in Series B-1 ExtensionCerevance, a Boston, MA-based company focused on developing precision novel therapeutics for central nervous system (CNS) diseases, raised $47M in Series B-1 Extension. The round was led by Agent Capital, Bioluminescence Ventures, and Doubl...
12.10.2021Augmented reality startup Magic Leap gets a reset with new fundingThis is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Magic Leap began its life in 2011 as a mysterious augmented reality startup from Florida that man...

Reviews 0

Sign up to leave a review

Sign up Log In